SOAT1 and cancer: SOCS1 has been primarily investigated in immune cells, where it functions as a potent inhibitor of inflammation through negative regulation of cytokine-activated JAK-STAT pathways but is emerging with important functions in cancer where it antagonizes cell growth, suggesting that SOCS1 expression in PGCC may contribute to their non-proliferative state (46, 47).